Rufinamide as add-on therapy in children with epileptic encephalopathies other than Lennox-Gastaut syndrome: A study of 34 patients.

CONCLUSION: Rufinamide may be used as a treatment option in DEE and REP other than LGS.
PMID: 32334364 [PubMed - as supplied by publisher]

Source: Epilepsy and Behaviour - April 21, 2020 Category: Neurology Authors: Caraballo RH, Pociecha J, Reyes G, Espeche A, Galichio S, Fasulo L, Semprino M Tags: Epilepsy Behav Source Type: research